The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • Gene obtained from curated document aligns with the Allele Registry but not with ClinVar data


Variant: NM_000527.5(LDLR):c.1435C>G (p.Leu479Val)

CA404086017

440643 (ClinVar)

Gene: LDLR
Condition: hypercholesterolemia, familial
Inheritance Mode: Semidominant inheritance
UUID: 1bd2a924-b5f5-4b22-8cd8-b9d296a837e3
Approved on: 2024-02-23
Published on: 2025-02-24

HGVS expressions

NM_000527.5:c.1435C>G
NM_000527.5(LDLR):c.1435C>G (p.Leu479Val)
NC_000019.10:g.11113611C>G
CM000681.2:g.11113611C>G
NC_000019.9:g.11224287C>G
CM000681.1:g.11224287C>G
NC_000019.8:g.11085287C>G
NG_009060.1:g.29231C>G
ENST00000252444.10:c.1693C>G
ENST00000559340.2:c.1435C>G
ENST00000560467.2:c.1315C>G
ENST00000558518.6:c.1435C>G
ENST00000252444.9:c.1689C>G
ENST00000455727.6:c.931C>G
ENST00000535915.5:c.1312C>G
ENST00000545707.5:c.1054C>G
ENST00000557933.5:c.1435C>G
ENST00000558013.5:c.1435C>G
ENST00000558518.5:c.1435C>G
ENST00000559340.1:c.156C>G
ENST00000560467.1:c.915C>G
NM_000527.4:c.1435C>G
NM_001195798.1:c.1435C>G
NM_001195799.1:c.1312C>G
NM_001195800.1:c.931C>G
NM_001195803.1:c.1054C>G
NM_001195798.2:c.1435C>G
NM_001195799.2:c.1312C>G
NM_001195800.2:c.931C>G
NM_001195803.2:c.1054C>G
More

Uncertain Significance

Met criteria codes 1
PM2
Not Met criteria codes 21
BS4 BS3 BS1 BS2 BP7 BP2 BP4 PS2 PS4 PS3 PS1 PP4 PP1 PP3 PM3 PM1 PM4 PM5 PM6 PVS1 BA1

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Familial Hypercholesterolemia Expert Panel Specifications to the ACMG/AMP Variant Classification Guidelines Version 1.2

PDF
Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Familial Hypercholesterolemia VCEP
The NM_000527.5(LDLR):c.1435C>G (p.Leu479Val) variant is classified as Uncertain significance - insufficient evidence for Familial Hypercholesterolemia by applying ACMG/AMP evidence code PM2 as defined by the ClinGen Familial Hypercholesterolemia Expert Panel LDLR-specific variant curation guidelines (specification version 1.2) on 23 February 2024. The supporting evidence is as follows: PM2: PopMax MAF = 0.00008 (0.008%) in African exomes (gnomAD v4.0.0).
Met criteria codes
PM2
PopMax MAF = 0.00008 (.008%) in African exomes (gnomAD version 4.0.0).
Not Met criteria codes
BS4
Not met.
BS3
No data available.
BS1
FAF not present in gnomAD v 2.1.1, so BS1 is not met.
BS2
Not met.
BP7
Not a synonymous variant.
BP2
Not met.
BP4
REVEL= 0.54
PS2
Not met.
PS4
Unknown diagnostic criteria in index case.
PS3
No data available.
PS1
Not met.
PP4
Not met.
PP1
Not met.
PP3
REVEL= 0.54. It is not above 0.75, splicing evaluation required. A) Not on limits B) variant is exonic and at least 50bp upstream/downstream from canonical donor site and creates GT MES Scores: de novo variant = -4.99 canonical donor = 5.46 Ratio de novo variant/canonical donor = -4.99/5.46 = -.91 , It is not above 0.9
PM3
Not met.
PM1
Not located in exon 4 or at a cysteine residue.
PM4
Not an in-frame deletion or insertion.
PM5
Not met.
PM6
Not met.
PVS1
Not a null variant.
BA1
FAF not present in gnomAD v 2.1.1, so BA1 is not met.
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.